Compare OSPN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSPN | MRVI |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United States |
| Employees | 341 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.5M | 449.6M |
| IPO Year | 1998 | 2020 |
| Metric | OSPN | MRVI |
|---|---|---|
| Price | $12.85 | $4.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $17.00 | $4.57 |
| AVG Volume (30 Days) | 537.8K | ★ 1.2M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | ★ 99.92 | N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $241,436,000.00 | $192,435,000.00 |
| Revenue This Year | $0.69 | N/A |
| Revenue Next Year | $1.96 | $9.04 |
| P/E Ratio | $8.74 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.00 | $1.67 |
| 52 Week High | $20.37 | $6.05 |
| Indicator | OSPN | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 66.60 |
| Support Level | $12.82 | $3.79 |
| Resistance Level | $13.20 | $4.02 |
| Average True Range (ATR) | 0.33 | 0.18 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 66.35 | 87.43 |
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.